Clinical application of DNA ploidy to cervical cancer screening: A review

doi:10.5306/wjco.v5.i5.931

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 5

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14139)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-26) series, Tables (1-17) series.

Item

Count

PDF

827

WORD

512

HTML

10593

Figures (1-26)

253

Tables (1-17)

179

Sum=12364

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

833

Download

942

Sum=1775

Dec 10, 2014 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Clin Oncol. Dec 10, 2014; 5(5): 931-965
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.931

Full Size Figure Download Figure

Figure 10 Given an aneuploid cell fraction, how many cells must be measured to get 1% chance of a real false negative or a 95% chance of a positive test result.

Citation: Garner D. Clinical application of DNA ploidy to cervical cancer screening: A review. World J Clin Oncol 2014; 5(5): 931-965
URL: https://www.wjgnet.com/2218-4333/full/v5/i5/931.htm
DOI: https://dx.doi.org/10.5306/wjco.v5.i5.931